Access cutting-edge peanut allergy treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access peanut allergy specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related peanut allergy treatment provided free
The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.
Sponsor: DBV Technologies
Check if you qualify for this peanut allergy clinical trial in Birmingham, AL
If you're searching for peanut allergy treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced peanut allergy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.